1. Home
  2. MPAA vs TTRX Comparison

MPAA vs TTRX Comparison

Compare MPAA & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorcar Parts  of America Inc.

MPAA

Motorcar Parts of America Inc.

HOLD

Current Price

$13.87

Market Cap

253.7M

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$10.32

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPAA
TTRX
Founded
1968
2015
Country
United States
United States
Employees
N/A
2
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.7M
281.2M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
MPAA
TTRX
Price
$13.87
$10.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$17.50
$8.00
AVG Volume (30 Days)
82.5K
90.4K
Earning Date
06-08-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
162.63
N/A
EPS
0.62
N/A
Revenue
$789,806,000.00
N/A
Revenue This Year
$1.50
N/A
Revenue Next Year
$7.42
N/A
P/E Ratio
$21.94
N/A
Revenue Growth
4.28
N/A
52 Week Low
$9.29
$2.57
52 Week High
$18.12
$11.69

Technical Indicators

Market Signals
Indicator
MPAA
TTRX
Relative Strength Index (RSI) 46.12 61.26
Support Level $13.51 $2.95
Resistance Level $13.81 $10.48
Average True Range (ATR) 0.62 0.84
MACD -0.06 -0.03
Stochastic Oscillator 24.50 73.76

Price Performance

Historical Comparison
MPAA
TTRX

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts, test solutions, and diagnostic equipment. Its replacement parts are mainly sold to automotive retail chain stores, warehouse distributors across North America, and automobile manufacturers for aftermarket and warranty replacement programs. The Company's test solutions and diagnostic equipment serve the automotive component and powertrain testing market. Its product portfolio includes rotating electrical products such as alternators and starters; brake-related products including brake calipers, brake rotors, brake pads, brake master cylinders, and wheel hub assemblies and bearings; and other products. Its segments are Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: